Voyager Therapeutics, Inc (VYGR) Covered Calls

You can sell covered calls on Voyager Therapeutics, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for VYGR (prices last updated Fri 12:15 PM ET):

Voyager Therapeutics, Inc (VYGR) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
24.80 +0.26 24.77 24.81 233K - 0.9B
Covered Calls For Voyager Therapeutics, Inc (VYGR)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Aug 16 25 1.90 22.91 8.3% 105%
Oct 18 25 3.60 21.21 17.0% 67.4%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Voyager Therapeutics, Inc., a clinical-stage gene therapy company, focuses on the development of treatments for patients suffering from severe neurological diseases. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1b clinical trials for the treatment of advanced Parkinson's disease. Its preclinical programs comprise VY-SOD101 for a monogenic form of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; Tau program, for tauopathies, including Alzheimer's disease, PSP, and FTD; and VY-NAV01 for severe chronic pain. The company has strategic collaboration agreements with AbbVie Inc.; Sanofi Genzyme; and the University of Massachusetts. Voyager Therapeutics, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.